发明名称 Chiral nitrogen-phosphorus ligands and their use for asymmetric hydrogenation of alkenes
摘要 The invention relates to a series of novel chiral nitrogen-phosphorus ligands of formulae (Ia) and (Ib):; wherein R1-R3 and X are as defined herein. The invention also relates to chiral metal complexes prepared with these chiral nitrogen-phosphorus ligands. The chiral metal complexes are useful as catalysts for carrying out asymmetric hydrogenation.
申请公布号 US8946418(B1) 申请公布日期 2015.02.03
申请号 US201414327076 申请日期 2014.07.09
申请人 Boehringer Ingelheim International GmbH 发明人 Haddad Nizar;Qu Bo;Savoie Jolaine;Senanayake Chris Hugh;Wei Xudong
分类号 C07F15/00;C07F9/6571;B01J31/22 主分类号 C07F15/00
代理机构 代理人 Morris Michael P.;Kershner David L.
主权项 1. A compound of formula Ia, Ib, or a mixture thereof: wherein: X is O, S, or —NR5; R1 is —(C1-C6)alkyl, —CF3, —(C3-C10)carbocyclyl, -(5- to 11-membered)heterocarbocyclyl, —(C6-C14)aryl, -(5 to 11-membered)heteroaryl, or ferrocenyl; wherein said —(C3-C10)carbocyclyl, -(5- to 11-membered)heterocarbocyclyl, —(C6-C14)aryl and -(5 to 11-membered)heteroaryl of said R1 is optionally substituted with 1 to 3 substituents independently selected from —O(C1-C6)alkyl, —(C1-C6)alkyl, and —CF3; R2 is H, —O(C1-C6)alkyl, —(C1-C6)alkyl, —(C3-C10)carbocyclyl, -(5- to 11-membered)heterocarbocyclyl, —(C6-C14)aryl, -(5 to 11-membered)heteroaryl, —NR5R6, or —SR5; wherein said —(C3-C10)carbocyclyl, -(5- to 11-membered)heterocarbocyclyl, —(C6-C14)aryl, and -(5 to 11-membered)heteroaryl of said R2 is optionally substituted with 1 to 3 substituents independently selected from —O(C1-C6)alkyl, —(C1-C6)alkyl, and —CF3; R3 is —(C1-C6)alkyl substituted with 1 to 3 (5- to 6-membered)heteroaryl; wherein the (5- to 6-membered)heteroaryl ring is optionally substituted with 1 to 3 R4 substituents independently selected from —O(C1-C6)alkyl, —N—(C1-C6 alkyl)2, —(C1-C6)alkyl, phenyl, (5- to 11-membered)heteroaryl and —CF3; or R3 is selected from the group consisting of ortho-substituted pyridine, oxazoline, and chiral oxazoline, wherein each of said ortho-substituted pyridine, oxazoline, and chiral oxazoline is optionally substituted with 1 to 3 R4 substituents independently selected from —O(C1-C6)alkyl, —N—(C1-C6 alkyl)2, —(C1-C6)alkyl, phenyl, (5- to 11-membered)heteroaryl and —CF3; R5 and R6 are each independently H, —(C1-C6)alkyl, —CF3, —(C3-C10)carbocyclyl, -(5- to 11-membered)heterocarbocyclyl, —(C6-C10)aryl, or -(5 to 11-membered)heteroaryl; wherein each —(C1-C6)alkyl, —CF3, —(C3-C10)carbocyclyl, -(5- to 11-membered)heterocarbocyclyl, —(C6-C10)aryl, and -(5 to 11-membered)heteroaryl of said R5 and R6 is optionally independently substituted with 1 to 3 substituents independently selected from halo, —O(C1-C6)alkyl, —(C1-C6)alkyl, and —CF3.
地址 Ingelheim am Rhein DE